Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$11,757,124
+$1,709,739 QoQ
Shares Held
46,722
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#845
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$503,280
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. ABBV ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
|
4,581 | $717,934 |
All Filings in ABBV
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $503,280 | 2,000 | Put | Sole | 2026-07-31 | |
| 2026-06-30 | $11,757,124 | 46,722 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $434,980 | 2,000 | Put | Sole | 2026-05-01 | |
| 2026-03-31 | $10,047,385 | 46,197 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $502,678 | 2,200 | Put | Sole | 2026-02-05 | |
| 2025-12-31 | $10,571,089 | 46,265 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $9,648,734 | 41,672 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $7,724,947 | 41,617 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,737,612 | 41,703 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,531,992 | 42,386 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,477,618 | 42,929 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $7,191,833 | 41,930 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,739,978 | 42,504 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,646,198 | 42,887 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,392,736 | 42,887 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,769,542 | 42,823 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,525,723 | 40,947 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $6,600,637 | 40,843 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,460,065 | 40,683 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,037,720 | 39,421 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,212,703 | 38,324 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,821,323 | 35,608 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,840,603 | 35,604 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,000,972 | 35,520 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,752,095 | 34,671 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,845,506 | 35,889 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,951,082 | 33,692 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,268,608 | 33,292 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,313,204 | 30,361 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||